Exelixis Inc (NASDAQ:EXEL)

22.18
BATS BZX Real-Time Price
As of 1:13pm ET
 -0.25 / -1.11%
Today’s Change
18.18
Today|||52-Week Range
27.35
+10.51%
Year-to-Date
Exelixis (EXEL) & Bristol Myers Team Up for Genitourinary Cancers
Jun 15 / Zacks.com - Paid Partner Content
Here's What Crushed Exelixis' Earnings
Jun 06 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close22.43
Today’s open22.13
Day’s range22.06 - 22.40
Volume36,129
Average volume (3 months)1,711,546
Market cap$7.2B
Data as of 1:13pm ET, 06/17/2021

Growth & Valuation

Earnings growth (last year)-65.82%
Earnings growth (this year)-4.29%
Earnings growth (next 5 years)+46.16%
Revenue growth (last year)+2.04%
P/E ratio108.2
Price/Sales6.46
Price/Book3.80

Competitors

 Today’s
change
Today’s
% change
SYNHSyneos Health Inc-0.07-0.08%
MEDPMedpace Holdings Inc+1.19+0.66%
ADPTAdaptive Biotechnolo...+1.65+4.35%
PRAHPRA Health Sciences ...+3.00+1.80%
Data as of 1:13pm ET, 06/17/2021

Financials

Next reporting dateAugust 4, 2021
EPS forecast (this quarter)$0.07
Annual revenue (last year)$987.5M
Annual profit (last year)$111.8M
Net profit margin11.32%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Alameda, California

Forecasts